Literature DB >> 10989935

Impairment of glucokinase translocation in cultured hepatocytes from OLETF and GK rats, animal models of type 2 diabetes.

Y Toyoda1, Y Ito, K Tanigawa, I Miwa.   

Abstract

We examined sugar-induced translocation of glucokinase in cultured hepatocytes from Otsuka Long-Evans Tokushima Fatty and Goto-Kakizaki rats, animal models of type 2 diabetes, and compared this with that in Long-Evans Tokushima Otsuka and Wistar rats, respectively, as control strains. When hepatocytes from the four strains were incubated with 5 mM glucose, glucokinase was present predominantly in the nuclei. Higher concentrations of glucose, 5 mM glucose plus 1 mM fructose, and 5 mM glucose plus 1 mM sorbitol all induced the translocation of glucokinase from the nucleus to the cytoplasm in hepatocytes from these rats. The extent of glucokinase translocation under these conditions, however, was less marked in both diabetic rat types than in the control rats. The extent of the phosphorylation of glucose as estimated by the release of 3H2O from [2- 3H] glucose is significantly lower in Goto-Kakizaki rats than in Wistar rats. The results indicate that the translocation of glucokinase is impaired in the hepatocytes of diabetic rats. They also suggest that the impaired translocation of glucokinase is associated with abnormal hepatic glucose metabolism in type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10989935     DOI: 10.1679/aohc.63.243

Source DB:  PubMed          Journal:  Arch Histol Cytol        ISSN: 0914-9465


  3 in total

1.  Glucagon induces translocation of glucokinase from the cytoplasm to the nucleus of hepatocytes by transfer between 6-phosphofructo 2-kinase/fructose 2,6-bisphosphatase-2 and the glucokinase regulatory protein.

Authors:  Kirsty S Cullen; Ziad H Al-Oanzi; Finbarr P M O'Harte; Loranne Agius; Catherine Arden
Journal:  Biochim Biophys Acta       Date:  2014-02-22

2.  To Explore the Pathogenesis of Vascular Lesion of Type 2 Diabetes Mellitus Based on the PI3K/Akt Signaling Pathway.

Authors:  Jia-Rong Gao; Xiu-Juan Qin; Zhao-Hui Fang; Li-Ping Han; Ming-Fei Guo; Nan-Nan Jiang
Journal:  J Diabetes Res       Date:  2019-04-17       Impact factor: 4.011

3.  Rare sugar D-psicose prevents progression and development of diabetes in T2DM model Otsuka Long-Evans Tokushima Fatty rats.

Authors:  Akram Hossain; Fuminori Yamaguchi; Kayoko Hirose; Toru Matsunaga; Li Sui; Yuko Hirata; Chisato Noguchi; Ayako Katagi; Kazuyo Kamitori; Youyi Dong; Ikuko Tsukamoto; Masaaki Tokuda
Journal:  Drug Des Devel Ther       Date:  2015-01-17       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.